Joshua is originally from Memphis, Tennessee and matriculated to UT Southwestern Medical Center in Dallas, TX in 2020. He joined the Siegwart lab in 2021 and is working on the development of three-component lipid nanoparticles (LNPs) as gene carriers. As seen with the COVID-19 vaccines, delivery of genetic material (in this case mRNA) has been very helpful and successful.
